Instructor Biography: Nir Barzilai
NIR BARZILAI is a chaired Professor of Medicine and Genetics at Albert Einstein College of Medicine and the Director of its Institute for Aging Research. He also is Director of the Paul F. Glenn Center for the Biology of Human Aging Research and of NIH’s Nathan Shock Centers of Excellence in the Basic Biology of Aging. He is also a Professor at NUS in Singapore. He received an NIH Merit Award for aiming to extend the healthy life span in rodents by biological interventions and numerous other prestigious awards, including the 2010 Irving S. Wright Award of Distinction in Aging Research and the 2018 IPSEN Longevity award. He is leading the TAME (Targeting/Taming Aging with Metformin) multi central study to prove that concept that multi morbidities of aging can be delayed in humans and change the FDA indications to allow for next generation interventions. He is a founder of CohBar Inc. (now public company) and Medical Advisor for Life Biosciences, serves on the board of AFAR, is a founding member of the Academy for Lifespan and Healthspan Research (AHLR) and co-founder of CohBar. He presents all over the world and has been featured in major papers, TV programs, and documentaries (TEDx and TEDMED).